AutoGenomics Withdraws IPO for Second Time | GenomeWeb

NEW YORK (GenomeWeb News) – AutoGenomics once again withdrew its planned initial public offering after failing to meet a Feb. 15 deadline to provide its latest financial information to the US Securities and Exchange Commission, a company official confirmed to GenomeWeb Daily News.

Ramanath Vairavan, senior vice president of sales and marketing for the Vista, Calif.-based molecular diagnostics firm, said that the company hopes to refile for an IPO in the second quarter.

Get the full story

This story is free
for registered users

Registering provides access to this and other free content.

Register now.

Already have an account?
Login Now.

In PLOS this week: genetic factors associated with facial features, a new mutation that makes individuals more prone to Brugada syndrome, and more.

Nutrigenomic companies offer gene-based diet advice, the Wall Street Journal reports.

Researchers have found a new kind of virus — one that starts out broken up into five parts.

Nature News explores the president's "science legacy."